Company page

Formycon Ag

Formycon AG, trading under the ticker FYB, is a public company based in Germany with a market capitalization of approximately €396.89 million. The company focuses on the development of biosimilars and has established a strong position in the biopharmaceutical industry. Formycon is committed to advancing healthcare solutions through innovative therapies.